Tirzepatide versus GLP-1 receptor agonists and stroke in patients with atrial fibrillation and type 2 diabetes
- DOI
- 10.1038/s41467-026-77047-5
- Published
- 2026-08-22
- Container
- Nature Communications
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-026-77047-5,
title = {Tirzepatide versus GLP-1 receptor agonists and stroke in patients with atrial fibrillation and type 2 diabetes},
author = {Chih-Lang Lin and Kuan-Chou Lin and Jung-Min Yu and Chia-Lun Chang and Yu-Yi Lin and Chih-Yuan Fang and Wan-Ming Chen and Szu-Yuan Wu},
year = {2026},
journal = {Nature Communications},
doi = {10.1038/s41467-026-77047-5},
url = {https://doi.org/10.1038/s41467-026-77047-5}
}RIS
TY - JOUR TI - Tirzepatide versus GLP-1 receptor agonists and stroke in patients with atrial fibrillation and type 2 diabetes AU - Chih-Lang Lin AU - Kuan-Chou Lin AU - Jung-Min Yu AU - Chia-Lun Chang AU - Yu-Yi Lin AU - Chih-Yuan Fang AU - Wan-Ming Chen AU - Szu-Yuan Wu PY - 2026 JO - Nature Communications DO - 10.1038/s41467-026-77047-5 UR - https://doi.org/10.1038/s41467-026-77047-5 ER -
APA
Lin, C., Lin, K., Yu, J., Chang, C., Lin, Y., Fang, C., Chen, W., & Wu, S. (2026). Tirzepatide versus GLP-1 receptor agonists and stroke in patients with atrial fibrillation and type 2 diabetes. Nature Communications. https://doi.org/10.1038/s41467-026-77047-5
Source records
- crossref · retrieved 2026-09-26T02:28:50.114Z